Dr. Pierfrancesco Corvo

Pierfrancesco Corvo, MD, PhD, is an Interventional Cardiologist consultant of Cardiovascular Center.

He has overall 20 years of professional experience.

Areas of Interest

Interventional procedures

• Chronic total occlusion
• Ischemic heart disease
• ASD/PFO treatment

Peripheral interventions

• Carotid Artery Intervention
• Renal artery Intervention
• Pudenda Artery intervention
• Periferal embolization

Valve replacement or treatment

• TAVR
• Mitraclip
• Herat failure
• Hypertension
• Invasive treatment

Education

• MD, University Policlinico Umberto I, Rome , Italy
• PhD, University Policlinico Umberto I, Rome , Italy

Specialty Training

• Senior Interventional Cardiologist, European Hospital-Aurelia Hospital, Rome, Italy
• Interventional Cardiologist, Azienda Ospedaliero Universitaria Maggiore della Carità di Novara, Italy
• Interventional Cardiologist, Policlinico Umberto I, Rome, Italy
• Interventional Cardiologist, Rome American Hospital, Rome, Italy

Working Experience

• Consultant, Department of Cardiology, Sheikh Khalifa Specialty Hospital, UAE
• Acting Co-director in Invasive and interventional cardiology Unit Aurelia Hospital-European Hospital
• Acting Co-director in Cardiology Clinic of 13 Centers of Private Clinic in Rome

Academic Activities

Certificate

• Certification of physician, MOH, UAE
• Certification of physician, Italy
• Board certification of Cardiology, Italy

Publication

• Use of abciximab prevents microcirculatory impairment in patients treated with coronary angioplasty for unstable angina: results of a prospective randomized study. Prati F, Kwiatkowski P, Caroselli C, Imola F, Manzoli A, Fouad T, Corvo P, Ramazzotti V. Catheter Cardiovasc Interv. 2005 Oct;66(2):165-9
• The RESTART project: high-dose atorvastatin helps control RESTenosis AfteR sTenting procedures at high risk for restenosis. Results from a prospective study and a matched control group comparison. Prati F, Imola F, Corvo P, Cernigliaro C, Fouadi T, Ramazzotti V, Manzoli A, Pappalardo A, Cera M. EuroIntervention. 2007 May;3(1):89-94.
• Scompenso cardiaco acuto e sindromi coronariche acute : una pericolosa combinazione. De Luca L, Corvo P, De Persio G, Tomai F. Giornale Italiano di Cardiologia 2007, vol. 8, p. 23S-31S
• Unusual treatment of coronary artery aneurysm. Mariano E, Corvo P, De Luca L, Tomai F. J Cardiovasc Med (Hagerstown). 2008 Aug;9(8):864-5
• Feasibility and safety of immediately returning patients transferred for percutaneous coronary intervention in a large metropolitan area. Tomai F, De Luca L, Nejat T, Corvo P, De Persio G, Altamura L, Michisanti M, Garofalo M, Mazzotti PV, Proietti F. G Ital Cardiol (Rome). 2010 Oct;11(10):783-8
• Long-Term Outcome of Provisional Side-Branch T-Stenting for the Treatment of Unprotected Distal Left Main Coronary Artery Diseas. De Luca L, Altamura L, Corvo P, De Persio G, Petrolini A, Ghini AS, Tomai F. Circulation 2010, vol. 122, A21544, ISSN: 0009-7322
• Role of platelet-monocyte interaction in the no-reflow phenomenon in patients with acute myocardial infarction. Aurigemma C, Corvo P, Scalone G, De Luca L, De Persio G, Altamura L, Coviello I, Lanza GA, Tomai F, Crea F. European Heart Journal 2010, vol. 31, p. 965, ISSN: 0195-668X
• Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease. De Luca L, Altamura L, Corvo P, De Persio G, Ghini AS, Petrolini A, Aurigemma C, Tomai F. Catheter Cardiovasc Interv. 2011 May 1;77(6):765-72.
• Effect of pre-infarction angina on platelet reactivity in acute myocardial infarction. Scalone G, Aurigemma C, Tomai F, Corvo P, Battipaglia I, Lanza GA, Crea F. Int J Cardiol. 2013 Jul 15;167(1):51-6
• Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN- AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute
• Myocardial Infarction). Niccoli G, Rigattieri S, De Vita MR, Valgimigli M, Corvo P, Fabbiocchi F, Romagnoli E, De Caterina AR, La Torre G, Lo Schiavo P, Tarantino F, Ferrari R, Tomai F, Olivares P, Cosentino N, D'Amario D, Leone AM, Porto I, Burzotta F, Trani C, Crea F. JACC Cardiovasc Interv. 2013 Jun;6(6):580-9
• A prospective registry on carotid artery revascularisation selected by consensus of a cardiovascular team. Tomai F, De Luca L, Weltert L, Ghini AS, Corvo P, De Persio G, Altamura L, Albano M, Borioni R, Garofalo M. EuroIntervention. 2014 Mar 20;9(11):1294-300
• One-year outcome from an all-comers population of patients with ST- segment elevation myocardial infarction treated with biolimus-eluting stent with biodegradable polymer. Tomai F, De Luca L, Altamura L, Versaci F, Pennacchi M, Proietti I, Ghini AS, Corvo P, De Persio G, Petrolini A, Tommasino A, Sardella G. Catheter Cardiovasc Interv. 2015 Feb 15;85(3):352-8
• Percutaneous recanalization of a chronic total left main coronary artery occlusion in an 8-year-old child after arterial switch surgery. Tomai F, Corvo P, Casenghi M, Cristofaletti A, Gagliardi GM. Can J Cardiol. 2015 Feb;31(2):227